Trial Profile
Pazopanib for soft tissue sarcoma (STS) in the first- line setting with denosumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Denosumab
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 17 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.